App-based therapy helps men improve control over premature ejaculation
A 12-week trial showed the Melonga App doubled ejaculation time and improved quality of life, with 22% of users no longer meeting premature ejaculation criteria, researchers said.
7 Articles
7 Articles
App-based therapy helps men improve control over premature ejaculation
A smartphone app designed to tackle the underlying psychological causes of premature ejaculation can significantly improve sex life and delay ejaculation, while offering a way to reduce stigma around the condition, say researchers.
A smartphone app could help men last longer in bed
A smartphone app designed to tackle the underlying psychological causes of premature ejaculation can significantly improve sex life and delay ejaculation, while offering a way to reduce stigma around the condition, say researchers. Data from the CLIMACS study are presented at the European Association of Urology Annual Congress (EAU26) in London. It is the first study to test a digital-first approach for treating premature ejaculation at home.
Enhance Endurance: Top Smartphone App for Men to Prolong Time in Bed
Premature ejaculation is believed to affect one in three men. Yevgen Chabanov / Alamy Recent preliminary results from a small randomized trial suggest that men dealing with premature ejaculation can enhance their control and prolong intercourse using a smartphone app. Premature ejaculation (PE) is identified as the most common sexual dysfunction in men; studies estimate [...] The post Enhance Endurance: Top Smartphone App for Men to Prolong Time…
Smartphone App Enhances Male Sexual Endurance, New Study Finds
A groundbreaking study presented at the European Association of Urology’s annual congress (EAU26) in London reveals that a novel smartphone application can effectively address the psychological factors underlying premature ejaculation (PE), greatly enhancing sexual satisfaction and ejaculatory control. This digital intervention, introduced through the CLIMACS study, represents the first randomized controlled trial examining the efficacy of a hom…
Coverage Details
Bias Distribution
- 75% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium



